Table 4.

Factors associated with cognitive troubles.

	Cognitive Trouble n = 9	No Cognitive Trouble n = 10	p
Man, n (%)	8 (88.9%)	7 (70%)	0.58
Age at study enrollment, years, median [IQR]	38 [30–42]	40 [28.5–55.3]	0.65
Duration of disease, years, median [IQR]	7 [1–8]	8.5 [3.75–32]	0.16
Past use of GC n (%)	1 (11.1)	4 (40)	0.28
Present use of GC n (%)	5 (55.6)	2 (20)	0.11
Past use of IS n (%)	1 (11.1)	2 (20)	0.60
Present use of IS n (%)	4 (44.4)	4 (40)	0.84
N° therapeutic lines, median [IQR]	1 [0–2]	1 [0–1.5]	0.93
Cognitive complaint n (%)	3 (33.3)	1 (10%)	0.30
Abnormal MRI/NBD n (%)	1 (11.1%)	3 (30%)	0.58
BSAS median [IQR]	31 [12.8–42]	7 [1.9–21.8]	0.046

BSAS: Behçet’s Syndrome Activity Score; GC: glucocorticosteroids; IQR: interquartile range; IS: immunosuppressants; MRI: molecular resonance imaging; NBD: neuro-Behçet’s disease.